Published in TB and Outbreaks Week, March 1st, 2005
According to recent research published in the journal Vaccine, "The reduced antigen content diphtheria, tetanus, and pertussis (dTpa) vaccine (Boostrix) has been shown to induce a strong booster response to all the vaccine components in 4- to 6-year-olds. However, anti-diphtheria antibody levels were observed to be lower when compared to the 'full strength' pediatric DTPa vaccine. To assess the impact of this difference on long-term protection, a mathematical model was developed to predict diphtheria antibody decay over...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.